PharmaCyte Biotech Files 8-K: Accountant Change

Ticker: PMCB · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1157075

Pharmacyte Biotech, Inc. 8-K Filing Summary
FieldDetail
CompanyPharmacyte Biotech, Inc. (PMCB)
Form Type8-K
Filed DateFeb 26, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: accountant-change, 8-K

TL;DR

PharmaCyte Biotech changed its accountant, filing an 8-K on 2/26/25.

AI Summary

PharmaCyte Biotech, Inc. filed an 8-K on February 26, 2025, reporting changes in its certifying accountant as of February 21, 2025. The company, previously known as NuVilex, Inc., is incorporated in Nevada and operates in the biological products sector.

Why It Matters

Changes in a company's certifying accountant can signal potential issues with financial reporting or internal controls, warranting investor attention.

Risk Assessment

Risk Level: low — This filing solely reports a change in the company's certifying accountant, which is a routine administrative event.

Key Players & Entities

  • PharmaCyte Biotech, Inc. (company) — Registrant
  • February 21, 2025 (date) — Date of earliest event reported
  • February 26, 2025 (date) — Date of report
  • NuVilex, Inc. (company) — Former company name

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report changes in PharmaCyte Biotech, Inc.'s certifying accountant, effective February 21, 2025.

When was this 8-K report filed?

This 8-K report was filed on February 26, 2025.

What was PharmaCyte Biotech, Inc.'s former name?

PharmaCyte Biotech, Inc.'s former name was NuVilex, Inc., with a name change date of March 24, 2009.

In which state is PharmaCyte Biotech, Inc. incorporated?

PharmaCyte Biotech, Inc. is incorporated in Nevada.

What is PharmaCyte Biotech, Inc.'s Standard Industrial Classification (SIC) code?

PharmaCyte Biotech, Inc.'s SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding PharmaCyte Biotech, Inc. (PMCB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.